Articles by Disease (Liver Cancer)

Improvement of Nonviral Gene Therapy by Epstein-Barr Virus (EBV)-based Plasmid Vectors

Journal: Current Gene Therapy
Volume: 2
Page: 379-392
Author(s): O. Mazda

The ‘Other’ Telomerase Inhibitors: Non-G-Quadruplex Interactive Agent, Non-Antisense, Non-Reverse Transcriptase Telomerase Inhibitors

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 2
Page: 589-603
Author(s): L. A. Beltz

Genetics of Cancer Susceptibility

Journal: Current Genomics
Volume: 3
Page: 379-388
Author(s): Rogelio Gonzalez-Sarmiento

Tamoxifen in the Treatment of Hepatocellular Carcinoma: 5-Year Results of the CLIP-1 Multicentre Randomised Controlled Trial

Journal: Current Pharmaceutical Design
Volume: 8
Page: 1013-1019
Author(s): M. Stanzione, S. Pignata, M. Di Maio, E. De Maio, O. G. Manghisi, M. Felder, M. Persico, M. Russo, F. Castiglione, I De Sio, A. Aiello, D. Mattera, F. Perrone, M. Calandra, G. Piai, S. Elba, F. Farinati, R. Mazzanti, L. E. Adinolfi, G. Capuano, F. Izzo, G. B. Gaeta, B. Daniele and C. Gallo

Articles by Disease (Liver Cancer)

Improvement of Nonviral Gene Therapy by Epstein-Barr Virus (EBV)-based Plasmid Vectors

The ‘Other’ Telomerase Inhibitors: Non-G-Quadruplex Interactive Agent, Non-Antisense, Non-Reverse Transcriptase Telomerase Inhibitors

Genetics of Cancer Susceptibility

Tamoxifen in the Treatment of Hepatocellular Carcinoma: 5-Year Results of the CLIP-1 Multicentre Randomised Controlled Trial

Non Steroidal Estrogen Antagonists: Current Status and Future Perspectives

Synthesis, Proton-Affinity and Anti-Cancer Properties of the Prodigiosin-Group Natural Products

Adenoviral Vector-Mediated Gene Transfer for Human Gene Therapy

Recent Developments of Rebeccamycin Analogues as Topoisomerase I Inhibitors and Antitumor Agents.

Drug-Metabolizing Enzymes Mechanisms and Functions

Protein Kinase C as a Drug Target Implications for Drug or Diet Prevention and Treatment of Cancer